MedTrace Logo

Patients With Rheumatoid Arthritis (RA) Treated With Rituximab in Kuopio University Hospital

NCT00854321 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 49

Last updated 2009-03-03

No results posted yet for this study

Summary

One centre follow-up study on safety and efficacy of treatment with rituximab among patients with RA during 4 year period. Basic data is collected for the national register of biologicals.

Conditions

Interventions

DRUG

rituximab

rituximab two 1000 mg intravenous infusions separated by two weeks

DRUG

rituximab, observational study amon patients with active RA

two 1000 mg intravenous infusions separated by 2 weeks

Sponsors & Collaborators

  • Kuopio University Hospital

    lead OTHER

Principal Investigators

  • Oili Kaipiainen-Seppänen, MD · Kuopio University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-11-30
Primary Completion
2008-07-31
Completion
2008-07-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00854321 on ClinicalTrials.gov